Ross TM - Search Results

1

Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.

Carter DM, Darby CA, Lefoley BC, Crevar CJ, Alefantis T, Oomen R, Anderson SF, Strugnell T, Cortés-Garcia G, Vogel TU, Parrington M, Kleanthous H, Ross TM. Carter DM, et al. Among authors: ross tm. J Virol. 2016 Apr 14;90(9):4720-4734. doi: 10.1128/JVI.03152-15. Print 2016 May. J Virol. 2016. PMID: 26912624 Free PMC article.

2

Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine.

Bright RA, Ross TM, Subbarao K, Robinson HL, Katz JM. Bright RA, et al. Among authors: ross tm. Virology. 2003 Apr 10;308(2):270-8. doi: 10.1016/s0042-6822(03)00008-4. Virology. 2003. PMID: 12706077 Free article.

3

Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d.

Bower JF, Yang X, Sodroski J, Ross TM. Bower JF, et al. Among authors: ross tm. J Virol. 2004 May;78(9):4710-9. doi: 10.1128/jvi.78.9.4710-4719.2004. J Virol. 2004. PMID: 15078953 Free PMC article.

4

Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle.

Young KR, Smith JM, Ross TM. Young KR, et al. Among authors: ross tm. Virology. 2004 Oct 1;327(2):262-72. doi: 10.1016/j.virol.2004.07.009. Virology. 2004. PMID: 15351214 Free article.

5

DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.

Bower JF, Green TD, Ross TM. Bower JF, et al. Among authors: ross tm. Virology. 2004 Oct 25;328(2):292-300. doi: 10.1016/j.virol.2004.07.031. Virology. 2004. PMID: 15464849 Free article.

6

Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.

McBurney SP, Young KR, Ross TM. McBurney SP, et al. Among authors: ross tm. Virology. 2007 Feb 20;358(2):334-46. doi: 10.1016/j.virol.2006.08.032. Epub 2006 Sep 28. Virology. 2007. PMID: 17011011 Free article.

7

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.

Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM. Bright RA, et al. Among authors: ross tm. Vaccine. 2007 May 10;25(19):3871-8. doi: 10.1016/j.vaccine.2007.01.106. Epub 2007 Feb 15. Vaccine. 2007. PMID: 17337102

8

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.

Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, Kumar NM, Pushko P, Smith G, Tumpey TM, Ross TM. Bright RA, et al. Among authors: ross tm. PLoS One. 2008 Jan 30;3(1):e1501. doi: 10.1371/journal.pone.0001501. PLoS One. 2008. PMID: 18231588 Free PMC article.

9

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

Mahmood K, Bright RA, Mytle N, Carter DM, Crevar CJ, Achenbach JE, Heaton PM, Tumpey TM, Ross TM. Mahmood K, et al. Among authors: ross tm. Vaccine. 2008 Oct 3;26(42):5393-9. doi: 10.1016/j.vaccine.2008.07.084. Epub 2008 Aug 14. Vaccine. 2008. PMID: 18706956

10

Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine.

Crevar CJ, Ross TM. Crevar CJ, et al. Among authors: ross tm. Virol J. 2008 Oct 28;5:131. doi: 10.1186/1743-422X-5-131. Virol J. 2008. PMID: 18957098 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters